BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29937989)

  • 1. A pilot study of circulating microRNAs as potential biomarkers of Fabry disease.
    Cammarata G; Scalia S; Colomba P; Zizzo C; Pisani A; Riccio E; Montalbano M; Alessandro R; Giordano A; Duro G
    Oncotarget; 2018 Jun; 9(44):27333-27345. PubMed ID: 29937989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis.
    Walasik I; Klicka K; Grzywa TM; Szymusik I; Włodarski P; Wielgoś M; Pietrzak B; Ludwin A
    Reprod Biol; 2023 Dec; 23(4):100796. PubMed ID: 37611342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
    Perez-Sanchez C; Font-Ugalde P; Ruiz-Limon P; Lopez-Pedrera C; Castro-Villegas MC; Abalos-Aguilera MC; Barbarroja N; Arias-de la Rosa I; Lopez-Montilla MD; Escudero-Contreras A; Lopez-Medina C; Collantes-Estevez E; Jimenez-Gomez Y
    Hum Mol Genet; 2018 Mar; 27(5):875-890. PubMed ID: 29329380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease.
    Lo Curto A; Taverna S; Costa MA; Passantino R; Augello G; Adamo G; Aiello A; Colomba P; Zizzo C; Zora M; Accardi G; Candore G; Francofonte D; Di Chiara T; Alessandro R; Caruso C; Duro G; Cammarata G
    Cells; 2021 Feb; 10(2):. PubMed ID: 33572275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex- and Sample Timing-Related Variation in Plasma of Healthy Volunteers.
    Mooney C; Raoof R; El-Naggar H; Sanz-Rodriguez A; Jimenez-Mateos EM; Henshall DC
    PLoS One; 2015; 10(12):e0145316. PubMed ID: 26699132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcardiac gradient of cardio-microRNAs in the failing heart.
    Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM
    Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Levels of MicroRNAs in Hypertrophic Cardiomyopathy: The Relationship With Left Ventricular Hypertrophy, Left Atrial Dilatation and Ventricular Depolarisation-Repolarisation Parameters.
    Sonsöz MR; Yilmaz M; Cevik E; Orta H; Bilge AK; Elitok A; Onur I; Komurcu-Bayrak E
    Heart Lung Circ; 2022 Feb; 31(2):199-206. PubMed ID: 34088630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accurate diagnosis of endometriosis using serum microRNAs.
    Moustafa S; Burn M; Mamillapalli R; Nematian S; Flores V; Taylor HS
    Am J Obstet Gynecol; 2020 Oct; 223(4):557.e1-557.e11. PubMed ID: 32165186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Signature of Circulating miRNAs Associated With Fibrous Dysplasia of Bone: the mirDys Study.
    Legrand MA; Millet M; Merle B; Rousseau JC; Hemmendinger A; Gineyts E; Sornay-Rendu E; Szulc P; Borel O; Croset M; Chapurlat R
    J Bone Miner Res; 2020 Oct; 35(10):1881-1892. PubMed ID: 32526052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
    J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.
    Joris V; Gomez EL; Menchi L; Lobysheva I; Di Mauro V; Esfahani H; Condorelli G; Balligand JL; Catalucci D; Dessy C
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2345-2357. PubMed ID: 29976767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis.
    Zeng N; Huang YQ; Yan YM; Hu ZQ; Zhang Z; Feng JX; Guo JS; Zhu JN; Fu YH; Wang XP; Zhang MZ; Duan JZ; Zheng XL; Xu JD; Shan ZX
    Mol Ther Nucleic Acids; 2021 Dec; 26():1035-1050. PubMed ID: 34786209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia.
    Tanaka F; Takashima S; Nadatani Y; Otani K; Hosomi S; Kamata N; Taira K; Nagami Y; Tanigawa T; Fukumoto S; Watanabe T; Murakami Y; Kawada N; Fujiwara Y
    Dig Dis Sci; 2020 Dec; 65(12):3493-3501. PubMed ID: 31974910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of miR-486-5p, miR-451a, miR-21-5p and monocyte to high-density lipoprotein cholesterol ratio in patients with acute myocardial infarction.
    Xu L; Tian L; Yan Z; Wang J; Xue T; Sun Q
    Heart Vessels; 2023 Mar; 38(3):318-331. PubMed ID: 36214846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of microRNAs in leukocytes and serum of asbestosis patients.
    Kauschke V; Philipp-Gehlhaar M; Schneider J
    Eur J Med Res; 2023 May; 28(1):175. PubMed ID: 37189132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring miRNA-mRNA regulatory network in cardiac pathology in Na
    Xue J; Zhou D; Poulsen O; Hartley I; Imamura T; Xie EX; Haddad GG
    Physiol Genomics; 2018 Oct; 50(10):846-861. PubMed ID: 30029588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
    Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling.
    Zhu H; Leung SW
    Diabetologia; 2023 Feb; 66(2):288-299. PubMed ID: 36269347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MicroRNA differential expression profile in tuberous sclerosis complex cell line TSC2
    Cai Y; Guo H; Li HZ; Wang WD; Zhang YS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):580-584. PubMed ID: 28816269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.